Albers Jeffrey W. sold Kymera Therapeutics ($KYMR) shares on the open market four times in the last year, totaling $1.06 million, with his most recent sale on December 8, 2025. His sales rank 4,794th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 8, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | S | Common Stock | 2252 | $90.30 | 0.0000 | 87,300,286 | 100.00% | 0.00% |
| Dec. 8, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | S | Common Stock | 2748 | $89.32 | 2,252.0000 | 87,300,286 | 54.96% | 0.00% |
| Dec. 8, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Common Stock | 5000 | $14.18 | 5,000.0000 | 87,300,286 | 9999.99% | 0.01% |
| Dec. 8, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Stock Option (Right to Buy) | 5000 | $0.00 | 7,000.0000 | 87,300,286 | 41.67% | 0.01% |
| Oct. 13, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 87,300,286 | 100.00% | 0.01% |
| Oct. 13, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Common Stock | 5000 | $10.34 | 5,000.0000 | 87,300,286 | 9999.99% | 0.01% |
| Oct. 13, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | S | Common Stock | 5000 | $59.19 | 0.0000 | 87,300,286 | 100.00% | 0.01% |
| June 25, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 75,043,991 | 9999.99% | 0.02% |
| June 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Stock Option (Right to Buy) | 6349 | $0.00 | 5,000.0000 | 75,043,991 | 55.94% | 0.01% |
| June 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Common Stock | 6349 | $10.34 | 6,349.0000 | 75,043,991 | 9999.99% | 0.01% |
| June 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | S | Common Stock | 6349 | $49.00 | 0.0000 | 75,043,991 | 100.00% | 0.01% |
| May 29, 2025 | Spyre Therapeutics, Inc. | $SYRE | Albers Jeffrey W. | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 60,275,561 | 9999.99% | 0.04% |
| Nov. 6, 2024 | Spyre Therapeutics, Inc. | $SYRE | Albers Jeffrey W. | Director | S | Common Stock | 6700 | $36.76 | 27,360.0000 | 0 | 19.67% | 0.00% |
| Oct. 25, 2024 | Spyre Therapeutics, Inc. | $SYRE | Albers Jeffrey W. | Director | S | Common Stock | 300 | $36.43 | 34,060.0000 | 0 | 0.87% | 0.00% |
| Aug. 26, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Stock Option (Right to Buy) | 5000 | $0.00 | 11,349.0000 | 58,365,499 | 30.58% | 0.01% |
| Aug. 26, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Common Stock | 5000 | $10.34 | 5,000.0000 | 58,365,499 | 9999.99% | 0.01% |
| Aug. 26, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | S | Common Stock | 5000 | $49.10 | 0.0000 | 58,365,499 | 100.00% | 0.01% |
| June 18, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 58,365,499 | 9999.99% | 0.03% |
| May 14, 2024 | Spyre Therapeutics, Inc. | $SYRE | Albers Jeffrey W. | Not found | A | Stock Option (Right to Buy) | 11323 | $0.00 | 11,323.0000 | 0 | 9999.99% | 0.00% |
| Feb. 20, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Stock Option (Right to Buy) | 615 | $0.00 | 20,734.0000 | 58,365,499 | 2.88% | 0.00% |
| Feb. 20, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Common Stock | 615 | $10.34 | 615.0000 | 58,365,499 | 9999.99% | 0.00% |
| Feb. 20, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | S | Common Stock | 615 | $39.07 | 0.0000 | 58,365,499 | 100.00% | 0.00% |
| Feb. 21, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Common Stock | 4385 | $10.34 | 4,385.0000 | 58,365,499 | 9999.99% | 0.01% |
| Feb. 21, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | S | Common Stock | 4385 | $39.05 | 0.0000 | 58,365,499 | 100.00% | 0.01% |
| Feb. 21, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Stock Option (Right to Buy) | 4385 | $0.00 | 16,349.0000 | 58,365,499 | 21.15% | 0.01% |
| Jan. 23, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Stock Option (Right to Buy) | 10000 | $0.00 | 21,349.0000 | 58,365,499 | 31.90% | 0.02% |
| Jan. 23, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | S | Common Stock | 10000 | $30.05 | 0.0000 | 58,365,499 | 100.00% | 0.02% |
| Jan. 23, 2024 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Not found | M | Common Stock | 10000 | $10.34 | 10,000.0000 | 58,365,499 | 9999.99% | 0.02% |
| Nov. 24, 2023 | Spyre Therapeutics, Inc. | $SYRE | Albers Jeffrey W. | Not found | C | Series A Preferred Stock | 859 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 24, 2023 | Spyre Therapeutics, Inc. | $SYRE | Albers Jeffrey W. | Not found | C | Common Stock | 34360 | $0.00 | 34,360.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2023 | Spyre Therapeutics, Inc. | $SYRE | Albers Jeffrey W. | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2023 | Spyre Therapeutics, Inc. | $SYRE | Albers Jeffrey W. | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Kymera Therapeutics, Inc. | $KYMR | Albers Jeffrey W. | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 53,933,229 | 9999.99% | 0.02% |